Bacofer-OD 30 Tablet
Baclofen 30 mg Extended Release Tablets — Once-Daily Anti-Spasticity Therapy
| Composition | Baclofen 30 mg (Extended Release) |
|---|---|
| Dosage Form | Extended Release Tablet |
| Pack Type | Alu-Alu Blister |
| Pack Size | 10 x 10 Tablets |
| MRP | ₹ 2550 |
| Therapy | G.P. + Orthopaedics + Gynaecology + Dental + ENT + Neuro — GABA-B Agonist (Extended Release) |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Bacofer-OD 30 Tablet
Bacofer-OD 30 Tablet is an extended-release formulation of Baclofen 30 mg designed for once-daily dosing. The ER matrix releases Baclofen gradually over 24 hours, maintaining therapeutic spinal-cord concentrations and replacing the conventional thrice-daily regimen — a major adherence improvement in chronic spasticity management.
Chronic spasticity is one of the most undertreated complications of neurological disease, largely because the standard three-times-daily Baclofen regimen is hard to comply with long-term. The ER formulation addresses this directly: a single morning dose provides 24-hour coverage with smoother plasma concentrations and reduced peak-trough fluctuations — minimising both drowsiness peaks and breakthrough spasticity troughs.
Bacofer-OD 30 is manufactured by Trumac Healthcare under WHO-GMP conditions and is available for monopoly-based PCD pharma franchise and third-party manufacturing — a premium high-margin neurology SKU.
Indications
- Long-term management of spasticity in MS, spinal cord injury, cerebral palsy
- Patients on conventional Baclofen with adherence issues on TID dosing
- Maintenance therapy after successful titration on immediate-release Baclofen
- Post-stroke spasticity requiring chronic management
Mechanism of Action
Extended-release Baclofen activates spinal GABA-B receptors continuously over 24 hours, providing steady inhibition of mono- and polysynaptic reflex transmission. The smoother pharmacokinetic profile reduces dosing-related sedation peaks while maintaining effective anti-spasticity coverage through the night and into the next morning.
Dosage & Administration
Adults: one Bacofer-OD 30 tablet once daily in the morning. Swallow whole — do not crush or chew. Patients should already be stabilised on conventional Baclofen 30 mg/day total before switching to OD format. Discontinue gradually.
Side Effects
Drowsiness, dizziness, weakness, nausea, fatigue, dry mouth (often less peak-related than with IR formulation). Constipation, urinary frequency.
Contraindications & Precautions
Hypersensitivity. Active peptic ulcer. Severe renal impairment. Patients not yet stabilised on conventional Baclofen. Caution in elderly, respiratory disease, seizure history. Avoid alcohol and sedatives. Do not crush the ER tablet.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Bacofer-OD 30 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Bacofer-OD 30 Tablet used for?
Bacofer-OD 30 is an extended-release Baclofen 30 mg tablet for once-daily management of spasticity in neurological diseases — improving adherence over the conventional thrice-daily regimen.
Can I switch directly from conventional Baclofen to Bacofer-OD?
Switch only after successful stabilisation on conventional Baclofen at a total daily dose of around 30 mg/day, under physician supervision.
Is Bacofer-OD 30 available for PCD pharma franchise?
Yes, Trumac Healthcare offers Bacofer-OD 30 on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Bacofer-OD 30 be stored?
Store below 30 °C in a dry place, away from direct sunlight and moisture. Swallow whole — do not crush or chew.
Is Bacofer-OD 30 WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Bacofer-10 Tablet — Baclofen 10 mg
- Bacofer-20 Tablet — Baclofen 20 mg
- Acomust-300 SR Tablet — Acotiamide 300 mg (Sustained Release) — DCGI Approved Molecule